BEXAROTENE

Generic: BEXAROTENE

Mylan Pharmaceuticals Inc.Manufacturer
ORALRoute
BEXAROTENEActive Substance
2014-08-12Original Approval

BEXAROTENE is FDA application ANDA203174, sponsored by BIONPHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
92 reports
2
OFF LABEL USE
59 reports
3
DISEASE PROGRESSION
40 reports
4
DEATH
34 reports
5
PRURITUS
25 reports
6
PRODUCT USE IN UNAPPROVED INDICATION
23 reports
7
CUTANEOUS T-CELL LYMPHOMA
21 reports
8
FATIGUE
21 reports
9
MALIGNANT NEOPLASM PROGRESSION
19 reports
10
CONDITION AGGRAVATED
18 reports